|
1
|
Groome PA, Bolejack V, Crowley JJ, et al:
The IASLC Lung Cancer Staging Project: validation of the proposals
for the revision of the T, N, and M descriptors and consequent
stage groupings in the forthcoming (seventh) edition of the TNM
classification of malignant tumours. J Thorac Oncol. 2:694–705.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martini N and Flehinger BJ: The role of
surgery in N2 lung cancer. Surg Clin North Am. 67:1037–1049.
1987.PubMed/NCBI
|
|
3
|
Andre F, Grunenwald D, Pignon JP, Dujon A,
Pujol JL, Brichon PY, Brouchet L, Quoix E, Westeel V and Le
Chevalier T: Survival of patients with resected N2 non-small-cell
lung cancer. Evidence for a subclassification and implications. J
Clin Oncol. 18:2981–2989. 2000.PubMed/NCBI
|
|
4
|
Albain KS, Rusch VW, Crowley JJ, et al:
Concurrent cisplatin/etoposide plus chest radiotherapy followed by
surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer:
mature results of Southwest Oncology Group phase II study 8805. J
Clin Oncol. 13:1880–1892. 1995.PubMed/NCBI
|
|
5
|
Martini N, Kris MG, Flehinger BJ, et al:
Preoperative chemotherapy for stage IIIa (N2) lung cancer: The
Sloan-Kettering experience with 136 patients. Ann Thorac Surg.
55:1365–1373; discussion 1373–1374. 1993. View Article : Google Scholar
|
|
6
|
Lorent N, De Leyn P, Lievens Y, Verbeken
E, Nackaerts K, Dooms C, Van Raemdonck D, Anrys B and Vansteenkiste
J: Leuven Lung Cancer Group: Long-term survival of surgically
staged IIIA-N2 non-small-cell lung cancer treated with surgical
combined modality approach: Analysis of a 7-year prospective
experience. Ann Oncol. 15:1645–1653. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rosell R, Gómez-Codina J, Camps C, et al:
A randomized trial comparing preoperative chemotherapy plus surgery
with surgery alone in patients with non-small-cell lung cancer. N
Engl J Med. 330:153–158. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pataer A, Kalhor N, Correa AM, et al:
University of Texas M. Histopathology. J Thorac Oncol. 7:825–832.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Betticher DC, Schmitz Hsu SF, Tötsch M, et
al: Mediastinal lymph node clearance after docetaxel-cisplatin
neoadjuvant chemotherapy is prognostic of survival in patients with
stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II
trial. J Clin Oncol. 21:1752–1759. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim YN, Yi CA, Lee KS, et al: A proposal
for combined MRI and PET/CT interpretation criteria for
preoperative nodal staging in non-small-cell lung cancer. Eur
Radiol. 22:1537–1546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goldstraw P, Crowley J, Chansky K, et al:
The IASLC Lung Cancer Staging Project: proposals for the revision
of the TNM stage groupings in the forthcoming (seventh) edition of
the TNM Classification of malignant tumours. J Thorac Oncol.
2:706–714. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miller AB, Hoogstraten B, Staquet M and
Winkler A: Reporting results of cancer treatment. Cancer.
47:207–214. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naruke T, Suemasu K and Ishikawa S: Lymph
node mapping and curability at various levels of metastasis in
resected lung cancer. J Thorac Cardiovasc Surg. 76:832–839.
1978.PubMed/NCBI
|
|
14
|
Pass HI, Pogrebniak HW, Steinberg SM,
Mulshine J and Minna J: Randomized trial of neoadjuvant therapy for
lung cancer, Interim analysis. Ann Thorac Surg. 53:992–998. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Roth JA, Fossella F, Komaki R, et al: A
randomized trial comparing perioperative chemotherapy and surgery
with surgery alone in resectable stage IIIA non-small-cell lung
cancer. J Natl Cancer Inst. 86:673–680. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Depierre A, Milleron B, Moro-Sibilot D, et
al: French Thoracic Cooperative Group: Preoperative chemotherapy
followed by surgery compared with primary surgery in resectable
stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J
Clin Oncol. 20:247–253. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagai K, Tsuchiya R, Mori T, Tada H,
Ichinose Y, Koike T and Kato H: Lung Cancer Surgical Study Group of
the Japan Clinical Oncology Group. A randomized trial comparing
induction chemotherapy followed by surgery with surgery alone for
patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
J Thorac Cardiovasc Surg. 125:254–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Meerbeeck JP, Kramer GW, Van Schil PE,
et al: European Organisation for Research and Treatment of
Cancer-Lung Cancer Group: Randomized controlled trial of resection
versus radiotherapy after induction chemotherapy in stage IIIA-N2
non-small-cell lung cancer. J Natl Cancer Inst. 99:442–450. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Silvestri GA, Gould MK, Margolis ML, et
al: Noninvasive staging of non-small cell lung cancer: ACCP
evidenced-based clinical practice guidelines (2nd edition). Chest.
132((Suppl 3)): 178S–201S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim HK, Choi YS, Kim K, Shim YM, Park K,
Ahn YC, Lee KS, Choi JY and Kim J: Outcomes of mediastinoscopy and
surgery with or without neoadjuvant therapy in patients with
non-small cell lung cancer who are N2 negative on positron emission
tomography and computed tomography. J Thorac Oncol. 6:336–342.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Al-Sarraf N, Aziz R, Gately K, Lucey J,
Wilson L, McGovern E and Young V: Pattern and predictors of occult
mediastinal lymph node involvement in non-small cell lung cancer
patients with negative mediastinal uptake on positron emission
tomography. Eur J Cardiothorac Surg. 33:104–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eberhardt W, Wilke H, Stamatis G, et al:
Preoperative chemotherapy followed by concurrent chemoradiation
therapy based on hyperfractionated accelerated radiotherapy and
definitive surgery in locally advanced non-small-cell lung cancer:
mature results of a phase II trial. J Clin Oncol. 16:622–634.
1998.PubMed/NCBI
|
|
23
|
Port JL, Korst RJ, Lee PC, et al: Surgical
resection for residual N2 disease after induction chemotherapy. Ann
Thorac Surg. 79:1686–1690. 2005. View Article : Google Scholar : PubMed/NCBI
|
